News & Updates
Filter by Specialty:
Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
Men with anticitrullinated peptide antibody (ACPA)-negative early rheumatoid arthritis (RA) tend to have favourable clinical outcomes than their female counterparts, a study has shown. However, such benefit is not seen in those with ACPA-positive early RA.
Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
10 Sep 2022Dactylitis predicts more severe joint damage, higher disease activity in axPsA
The presence of dactylitis in patients with axial psoriatic arthritis (axPsA) may result in higher disease activity and more severe joint damage compared to those without, reports a study.
Dactylitis predicts more severe joint damage, higher disease activity in axPsA
10 Sep 2022Malnutrition tied to poor survival in metastatic cervical cancer
Low serum albumin levels appear to be an important risk factor for poor survival outcomes among patients with metastatic cervical cancer, a recent study has found.
Malnutrition tied to poor survival in metastatic cervical cancer
10 Sep 2022Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
Despite having no such history, about a third of patients with Parkinson’s disease (PD) show evidence of thrombocytopaenia or platelet dysfunction, reports a recent study.
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
10 Sep 2022COVID-19 lockdown weakens metabolism in people with glucose intolerance
In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.
COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
In patients with metastatic colorectal cancer (mCRC), using trifluridine/tipiracil with bevacizumab is a safe and effective treatment for refractory disease, a recent study has found.
Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
09 Sep 2022Low-dose methotrexate-related melanoma risk considered negligible
Individuals exposed to low-dose methotrexate risk developing melanoma, although the absolute risk increase remains very low, as shown in a recent meta-analysis.
Low-dose methotrexate-related melanoma risk considered negligible
09 Sep 2022Cathepsin S levels predict survival in NSTE-ACS patients
Circulating cathepsin S (CTSS) is significantly associated with long-term mortality and may be used to enhance risk stratification of patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) over the Global Registry of Acute Coronary Events (GRACE) risk score, suggests a study.
Cathepsin S levels predict survival in NSTE-ACS patients
09 Sep 2022Slow progress to heart failure, death seen in patients with d-TGA after atrial switch
Most adults with d-loop transposition of the great arteries (d-TGA) after atrial switch operation exhibit slow progression to end-stage heart failure or death, according to a recent study.